# Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

> **NCT00025402** · PHASE3 · UNKNOWN · sponsor: **III. Medizinische Klinik Mannheim** · enrollment: 1000 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** recombinant interferon alfa
- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** etoposide
- **DRUG:** hydroxyurea
- **DRUG:** idarubicin
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00025402
- **Lead sponsor:** III. Medizinische Klinik Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1997-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00025402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00025402, "Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00025402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*